COR.NYSECencora, INC

Form 4: Cencora CFO James F. Cleary Reports Stock Transactions Following Vesting of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Cencora's Chief Financial Officer, James F. Cleary, reported the acquisition of common stock and disposal of shares to cover tax obligations following the vesting of restricted stock units.

Summary

  • James F. Cleary, the Chief Financial Officer of Cencora, Inc., filed a Form 4 detailing transactions related to his company stock.
  • The transactions occurred on November 8, 2024, and involved the vesting of restricted stock units (RSUs).
  • Cleary acquired a total of 8,477 shares of common stock through the vesting of RSUs.
  • He also disposed of 3,791 shares of common stock to satisfy tax withholding obligations at a price of $248.41 per share.
  • After these transactions, Cleary's direct holdings of Cencora common stock increased to 118,742.3479 shares.
  • He also holds 4,879 restricted stock units.

Sentiment

Score: 6

Explanation: The document reflects routine transactions related to executive compensation. It is neither particularly positive nor negative, but rather a standard disclosure.

Positives

  • The vesting of restricted stock units indicates that performance milestones were likely met.
  • The increase in direct share ownership by the CFO could be seen as a positive sign of confidence in the company.

Negatives

  • The sale of shares to cover tax obligations, while standard, does reduce the overall shareholding of the CFO.

Risks

  • There are no specific risks highlighted in this document.
  • The document is a routine filing related to stock transactions.

Industry Context

This is a standard SEC Form 4 filing related to insider transactions, which is common for publicly traded companies. It reflects the compensation structure of the company and the vesting schedule of equity awards.

Comparison to Industry Standards

  • Form 4 filings are a standard practice for all publicly traded companies in the US, and Cencora's filing is consistent with these requirements.
  • The vesting schedules and tax withholding practices are typical for executive compensation packages in the industry.
  • Comparable companies such as McKesson and Cardinal Health also regularly file similar Form 4 documents for their executives.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect the standard vesting of executive compensation.
  • The sale of shares for tax obligations has a negligible impact on the overall share price.

Key Dates

DateDescription
11/10/2022First vesting date for some of the restricted stock units.
11/10/2023Second vesting date for some of the restricted stock units.
11/09/2023First vesting date for some of the restricted stock units.
11/08/2024Date of the reported transactions, including vesting of RSUs and sale of shares for tax obligations.
11/09/2024Second vesting date for some of the restricted stock units.
11/10/2024Final vesting date for some of the restricted stock units.
11/08/2025Second vesting date for some of the restricted stock units.
11/09/2025Final vesting date for some of the restricted stock units.
11/08/2026Final vesting date for some of the restricted stock units.
11/13/2024Date the Form 4 was signed.

Keywords

Cencora, James F. Cleary, Form 4, Restricted Stock Units, Stock Transactions, Insider Trading, SEC Filing, Share Ownership, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.